Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
Phoebe Wright, PharmD, MSc
Advertisement
Articles by Phoebe Wright, PharmD, MSc
Advertisement
Latest Updated Articles
- Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model
Published: March 16th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
3
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
